Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sophie H. A. E. Derks"'
Autor:
Yulun Wu, Sophie H. A. E. Derks, Tobias C. Wood, Erik de Blois, Astrid A. M. van der Veldt, Marion Smits, Esther A. H. Warnert
Publikováno v:
European Radiology Experimental, Vol 7, Iss 1, Pp 1-12 (2023)
Abstract Background Dynamic glucose-enhanced (DGE) chemical exchange saturation transfer (CEST) has the potential to characterize glucose metabolism in brain metastases. Since the effect size of DGE CEST is small at 3 T (
Externí odkaz:
https://doaj.org/article/c11cb6e1603f42038b963cdfefbb119e
Autor:
Yulun Wu, Tobias C. Wood, Sophie H. A. E. Derks, Ilanah J. Pruis, Sebastian van der Voort, Sophie E. M. Veldhuijzen van Zanten, Marion Smits, Esther A. H. Warnert
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Amide proton transfer (APT)-weighted chemical exchange saturation transfer (CEST) imaging is a recent MRI technique making its way into clinical application. In this work, we investigated whether APT-weighted CEST imaging can provide reprodu
Externí odkaz:
https://doaj.org/article/1e57fac330164976bb550f6f78e81dc5
Autor:
Sophie H. A. E. Derks, Joost L. M. Jongen, Edgar L. van der Meer, Li Shen Ho, Cleo Slagter, Arjen Joosse, Maja J. A. de Jonge, Joost W. Schouten, Esther Oomen-de Hoop, Martin J. van den Bent, Astrid A. M. van der Veldt
Publikováno v:
Cancers, 15(5):1461. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers
Volume 15
Issue 5
Pages: 1461
Cancers
Volume 15
Issue 5
Pages: 1461
BACKGROUND: Melanoma brain metastasis (MBM) is associated with poor outcome, but targeted therapies (TTs) and immune checkpoint inhibitors (ICIs) have revolutionized treatment over the past decade. We assessed the impact of these treatments in a real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e5c2309ee9bb42136d092c11ee7f91
https://pure.eur.nl/en/publications/d4306abb-8481-46b4-b913-0def3f223af8
https://pure.eur.nl/en/publications/d4306abb-8481-46b4-b913-0def3f223af8
Publikováno v:
The British Journal of Radiology. 95
Imaging of brain metastases (BMs) has advanced greatly over the past decade. In this review, we discuss the main challenges that BMs pose in clinical practice and describe the role of imaging. Firstly, we describe the increased incidence of BMs of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5605dc5f47c8b2e18007320a2e2ebe
https://doi.org/10.1259/bjr.20210944
https://doi.org/10.1259/bjr.20210944
Publikováno v:
Neuro-Oncology, 23(11), 1983-1984. Oxford University Press
Neuro-Oncology
Neuro-Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b57ca946cc094f22612e2d59f3d3d8d
http://www.scopus.com/inward/record.url?scp=85119502824&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85119502824&partnerID=8YFLogxK
Autor:
Joost W. Schouten, M. J. van den Bent, A.A.M. Van der Veldt, C Slagter, Arjen Joosse, Joost L M Jongen, Sophie H A E Derks
Publikováno v:
Neuro-Oncology. 23:ii43-ii43
BACKGROUND Until recently, patients with melanoma brain metastases (MBMs) had limited therapeutic options. With the arrival of immune checkpoint inhibitors (ICIs), targeted therapy (TT) and advances in stereotactic radiotherapy (SRT), treatment has i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a081062790840a1b3a21d891f4f8669a
https://doi.org/10.1093/neuonc/noab180.147
https://doi.org/10.1093/neuonc/noab180.147